PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway.\', \'Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.\', \'Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.\', \'European Program for Intervention Epidemiology Training, European Centre for Disease Prevention and Control, Stockholm, Sweden.\', \'Department of Virology, Norwegian Institute of Public Health, Oslo, Norway.\', \'Department of Infectious Disease Registries, Norwegian Institute of Public Health, Oslo, Norway.\', \'Department of Clinical Medicine, University of Bergen, Bergen, Norway.\', \'Department of Anaesthesia and Intensive Care, Haukeland University Hospital, Bergen, Norway.\', \'Norwegian Intensive Care and Pandemic Registry, Haukeland University Hospital, Bergen, Norway.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.2807/1560-7917.ES.2022.27.4.2200077
?:doi
?:hasPublicationType
?:journal
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
is ?:pmid of
?:pmid
?:pmid
  • 35086614
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all